RESTful clients can update the score by invocating the same URL through a PUT invocation while also passing query parameters. Again, the program will return a JSON-based representation of the score ...

TheServerSide has published a number of articles on the tenets of effective RESTful web service design, along with examples of how to actually create a cloud-native application using Spring Boot and ...

In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...

NEW DELHI: A wave of affordable generic versions of Ozempic and Wegovy (semaglutide) has rapidly captured around 20% of the nearly Rs 1,600 crore weight-loss market within days of launch, following ...

Weight-loss drugs like Ozempic and Mounjaro are transforming India’s obesity and diabetes treatment, spurring a generics boom after patent expiry. Prices have dropped, demand has surged, but experts ...

The rapid entry of semaglutide generics is beginning to weigh on the growth of Eli Lilly’s tirzepatide brand Mounjaro, even as the broader market expands, data from pharma market intelligence and data ...

Entering its fourth decade of known existence, human immunodeficiency virus (HIV) remains a formidable foe. Without an effective vaccine available, the global incidence of AIDS cases continues to rise ...

Multiple dapagliflozin generic approvals are expected to intensify near-term market competition, requiring manufacturers to coordinate production readiness, launch timing, and labeling compliance ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

The US has announced up to 100% tariffs on imported patented drugs and certain pharmaceutical ingredients, citing national security and supply chain concerns. India’s $9.7 billion generic drug exports ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...